Loading...
Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats
BACKGROUND: Abaloparatide is a parathyroid hormone receptor agonist that increases bone formation and reduces vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis. Animal studies indicate abaloparatide stimulates vertebral bone formation and enhances bony bridging and b...
Na minha lista:
| Udgivet i: | JOR Spine |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984001/ https://ncbi.nlm.nih.gov/pubmed/33778406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jsp2.1132 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|